Publications To Date


    Filter Publications

    PAGE 1 OF 28 | DISPLAYING 1 - 15 OF 412 RESULTS

    Zeng Z, Fu J, Cibulskis C...Wistuba II, Liu XS, Wu C Cross-site concordance evaluation of tumor DNA and RNA sequencing platforms for the CIMAC-CIDC network., , Clin Cancer Res, Dec 16, 2020

    Briest F, Koziolek EJ, Albrecht J...Brenner W, Baum RP, Grabowski P Does the proteasome inhibitor bortezomib sensitize to DNA-damaging therapy in gastroenteropancreatic neuroendocrine neoplasms? – A preclinical assessment in vitro and in vivo., , Neoplasia, Nov 26, 2020

    Segar JM, Pandey R, Farr KJ, Nagle R, LeBeau L, Gonzalez VJ, Chalasani P Clinicopathological and Molecular Characteristics of Pleomorphic Invasive Lobular Carcinoma., , Int J Breast Cancer, Nov 23, 2020

    Pudelko L, Jaehrling F, Reusch C...Rosell R, Schumacher KM, Karachaliou N SHP2 Inhibition Influences Therapeutic Response to Tepotinib in Tumors with MET Alterations., , iScience, Nov 21, 2020

    Busse A, Mochmann LH, Spenke C, Arsenic R, Briest, F, Jöhrens K, Lammert H, Sipos B, Kühl AA, Wirtz R, Pavel M, Hummel M, Kaemmerer D, Baum RP, Grabowski P Immunoprofiling in Neuroendocrine Neoplasms Unveil Immunosuppressive Microenvironment., , Cancers , Nov 20, 2020

    Bilusic M, Girardi D, Zhou Y...Flieder D, Gray P, Plimack E Molecular Profiling of Exceptional Responders to Cancer Therapy., , Oncologist, Nov 20, 2020

    Farrow NE, Holl EK, Jung J...Tyler DS, Nair SK, Beasley GM Characterization of Sentinel Lymph Node Immune Signatures and Implications for Risk Stratification for Adjuvant Therapy in Melanoma., , Ann Surg Oncol, Nov 18, 2020

    Lee YS, Lee WS, Kim CW...Kim WR, Chon HJ, Kim C Oncolytic vaccinia virus reinvigorates peritoneal immunity and cooperates with immune checkpoint inhibitor to suppress peritoneal carcinomatosis in colon cancer., , J Immunother Cancer, Nov 17, 2020

    Liang CW, Yang CY, Flavin R, Fletcher JA, Lu TP, Lai IR, Li YI, Chang YL, Lee JC Loss of SFRP1 expression is a key progression event in gastrointestinal stromal tumor pathogenesis., , Hum Pathol, Nov 11, 2020

    Tan GF, Goh S, Lim AH...Chuan-Young Ng C, Teh BT, Chan JY Bizarre giant cells in human angiosarcoma exhibit chemoresistance and confer poor survival outcomes., , Cancer Sci, Nov 09, 2020

    Selvanesan BC, Meena K, Beck A, Meheus L, Lara O, Rooman I, Gravekamp C Nicotinamide combined with gemcitabine is an immunomodulatory therapy that restrains pancreatic cancer in mice., , J Immunother Cancer, Nov 06, 2020

    Qin Y, Bollin K, de Macedo MP...Lazar AJ, Hwu P, Patel SP Immune profiling of uveal melanoma identifies a potential signature associated with response to immunotherapy., , J Immunother Cancer, Nov 02, 2020

    Kim K, Sohn YJ, Lee R, Yoo HJ, Kang JY, Choi N, Na D, Yeon JH Cancer-Associated Fibroblasts Differentiated by Exosomes Isolated from Cancer Cells Promote Cancer Cell Invasion., , Int J Mol Sci, Nov 01, 2020

    Yabuno A, Matsushita H, Hamano T...Fujiwara K, Kakimi K, Hasegawa K Identification of serum cytokine clusters associated with outcomes in ovarian clear cell carcinoma., , Sci Rep, Oct 29, 2020

    Groeneveldt C, Kinderman P, van den Wollenberg DJM, van den Oever RL, Middelburg J, Mustafa DAM, Hoeben RC, van der Burg SH, van Hall T, van Montfoort N Preconditioning of the tumor microenvironment with oncolytic reovirus converts CD3-bispecific antibody treatment into effective immunotherapy., , J Immunother Cancer, Oct 20, 2020